Sites facing mixed operating conditions
A new CenterWatch survey presents mixed signals about current operating conditions at investigative sites and reveals a complex picture of a market in flux. Overall clinical trial volume and site profitability have grown, but at the same time, as drug development programs have become more complex and target smaller patient populations, competition has intensified for the pocket of clinical trial activity considered the “bread and butter” of the industry.
Growing role for AMC clinical trial offices
As federal funding for clinical research continues to decrease, academic medical centers (AMCs) are strengthening clinical trial offices (CTOs) on their campuses. Though challenges run the gamut of turnaround time, stretched resources and faculty issues, rising benefits such as improved start-up times, new funding and expanding service offerings show that CTOs are gaining visibility and leverage within AMCs.
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.